Cellectar BiosciencesCLRB
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 37 institutions reported holding Cellectar Biosciences Inc. (CLRB) in their 13F filings, down 8 from Q1 2024. 5 opened new positions and 13 sold out. The largest holders were AIGH Capital Management LLC ($6.9M), Rosalind Advisors, Inc. ($6.8M) and Nantahala Capital Management, LLC ($4.6M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Cellectar Biosciences Inc.
- CUSIP
- 15117F807
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $362K |
| Exits | 13 | $1.6M |
All 13F filers, Q1 2024 → Q2 2024: 3,232,022 shares bought and 768,714 shares sold, net +2,463,308 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 37 holders
| AIGH Capital Management LLC | 3.35% | Add +8.3% | 3,036,187 | $6.9M |
| Rosalind Advisors, Inc. | 5.35% | Add +335.4% | 2,705,616 | $6.8M |
| Nantahala Capital Management, LLC | 0.46% | Reduce -2.1% | 1,833,325 | $4.6M |
| Vanguard Group Inc. | 0.00% | Add +31.3% | 1,563,986 | $3.9M |
| ADAR1 Capital Management, LLC | 0.34% | Add +6.2% | 682,094 | $1.7M |
| Geode Capital Management, LLC | 0.00% | Add +7.9% | 341,186 | $853K |
| BlackRock Inc. | 0.00% | Add +60.8% | 228,930 | $572K |
| Barclays PLC | 0.00% | Reduce -49.1% | 172,197 | $430K |
| Hudson Bay Capital Management LP | 0.00% | No change | 150,000 | $375K |
| State Street Corp. | 0.00% | Add +10.8% | 116,814 | $292K |
| Morgan Stanley | 0.00% | Add +292.6% | 83,442 | $209K |
| Acuta Capital Partners, LLC | 0.15% | Reduce -50.9% | 70,500 | $176K |
| XTX Topco Ltd | 0.01% | Add +432.4% | 63,304 | $158K |
| Bank of America Corp. | 0.00% | Add +225.2% | 63,074 | $158K |
| Northern Trust Corp. | 0.00% | Add +16.7% | 61,094 | $153K |
| JPMorgan Chase & Co. | 0.00% | New | 51,115 | $128K |
| Citadel Advisors | 0.00% | Reduce -57.3% | 50,227 | $126K |
| Susquehanna International Group, LLP | 0.00% | Add +156.4% | 45,751 | $114K |
| Millennium Management | 0.00% | New | 42,647 | $107K |
| Jane Street Group, LLC | 0.00% | Reduce -29.5% | 41,865 | $105K |
| Goldman Sachs Group Inc. | 0.00% | New | 35,000 | $88K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +486.9% | 31,825 | $80K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | No change | 30,000 | $75K |
| Integrated Wealth Concepts LLC | 0.00% | No change | 20,000 | $50K |
| Verition Fund Management LLC | 0.00% | New | 15,217 | $38K |
| UBS Group AG | 0.00% | Add +148.7% | 14,800 | $37K |
| Commerce Bank | 0.00% | Reduce -12.5% | 14,000 | $35K |
| Coastal Bridge Advisors, LLC | 0.01% | Reduce -31.3% | 11,000 | $28K |
| Simplex Trading, LLC | 0.00% | Add +122.7% | 8,192 | $20K |
| Group One Trading LLC | 0.00% | Reduce -38.1% | 4,954 | $12K |
| Osaic Holdings, Inc. | 0.00% | Add +446.3% | 2,846 | $7K |
| Redwood Wealth Management Group, LLC | 0.00% | New | 1,000 | $3K |
| Bfsg, LLC | 0.00% | No change | 1,000 | $3K |
| US Bancorp \de | 0.00% | Add +35.1% | 385 | $963 |
| EnRich Financial Partners LLC | 0.00% | No change | 102 | $255 |
| Harbour Investments, Inc. | 0.00% | No change | 40 | $100 |
| AllSquare Wealth Management LLC | 0.00% | No change | 18 | $45 |
"% of holder's portfolio" is CLRB's weight in each manager's 13F, not the share of Cellectar Biosciences Inc. the manager owns.